Empowering Cancer Immunotherapy with Artificial Intelligence

Innovative software solutions to guide the discovery of neoantigen-based personalized immunotherapies and biomarkers.

Artificial Intelligence
Artificial Intelligence
Proprietary machine learning algorithms and data to predict antigen presentation and immunogenicity
Applied to the selection of patient specific targets in immuno-oncology clinical trials
Personalized<br/>Cancer Medicine
Cancer Medicine
Truly personalized and novel cancer immunotherapies to empower your neoantigen clinical trial success